Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient

The immunosuppressant tacrolimus has a narrow therapeutic window, necessitating therapeutic drug monitoring to maintain efficacy and minimise toxicity. There are very few reports examining the impact of impaired biliary excretion on tacrolimus blood levels or toxicity. We report the case of a 26-yea...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel Chan, Michael T. Burke, David W. Johnson, Ross S. Francis, David W. Mudge
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Transplantation
Online Access:http://dx.doi.org/10.1155/2017/9096435
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The immunosuppressant tacrolimus has a narrow therapeutic window, necessitating therapeutic drug monitoring to maintain efficacy and minimise toxicity. There are very few reports examining the impact of impaired biliary excretion on tacrolimus blood levels or toxicity. We report the case of a 26-year-old combined liver and kidney transplant recipient, who developed acute biliary obstruction leading to tacrolimus toxicity with very high blood tacrolimus levels. Despite a careful evaluation, no alternative cause was found for her acute kidney injury, and her kidney function returned to previous baseline within several days following treatment of the biliary obstruction and temporary withdrawal of tacrolimus.
ISSN:2090-6943
2090-6951